Immune checkpoint inhibitors-associated cardiotoxicity in immunotherapy trials on gastrointestinal cancer patients

Lignende værker

• Anti-PD-1 antibody HX008 combined with oxaliplatin plus capecitabine for advanced gastric or esophagogastric junction cancer: a multicenter, single-arm, open-label, phase Ib trial
  af: Jianming Xu, et al.
  Udgivet: (2021-01-01)
• HX008: a humanized PD-1 blocking antibody with potent antitumor activity and superior pharmacologic properties
  af: Jibin Zhang, et al.
  Udgivet: (2020-01-01)
• Phase I study of pucotenlimab (HX008), an anti-PD-1 antibody, for patients with advanced solid tumors
  af: Rujiao Liu, et al.
  Udgivet: (2021-05-01)
• Safety and efficacy of Pucotenlimab (HX008) - a humanized immunoglobulin G4 monoclonal antibody in patients with locally advanced or metastatic melanoma: a single-arm, multicenter, phase II study
  af: Chuanliang Cui, et al.
  Udgivet: (2023-02-01)
• From HX-Groups to HX-Polygroups
  af: Seyed Sh. Mousavi, et al.
  Udgivet: (2023-12-01)